Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 |
---|---|---|---|---|---|
Gross Sales | 2,238.1 | 1,864.35 | 1,621.75 | 1,278.49 | 971.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,238.1 | 1,864.35 | 1,621.75 | 1,278.49 | 971.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 27.4 | 9.25 | 35.82 | 14.04 | 5.98 |
Total Income | 2,265.5 | 1,873.6 | 1,657.57 | 1,292.52 | 977.38 |
Total Expenditure | 1,653.4 | 1,383.04 | 1,180.97 | 876.28 | 701.4 |
PBIDT | 612.1 | 490.56 | 476.6 | 416.25 | 275.98 |
Interest | 63.5 | 30.67 | 25.13 | 12.17 | 25.09 |
PBDT | 548.6 | 459.89 | 451.47 | 404.07 | 250.89 |
Depreciation | 124.7 | 100.25 | 93.83 | 54.04 | 52.9 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 113.9 | 90.9 | 87.1 | 91.5 | 53.44 |
Deferred Tax | 1.6 | 4.23 | 3.39 | -1.94 | -2.3 |
Reported Profit After Tax | 308.4 | 264.52 | 267.14 | 260.47 | 146.86 |
Minority Interest After NP | 25.7 | 19.84 | 24.09 | 8.47 | 3.44 |
Net Profit after Minority Interest | 282.7 | 244.67 | 243.05 | 252 | 143.42 |
Extra-ordinary Items | 0 | 0 | 11.08 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 282.7 | 244.67 | 231.97 | 252 | 143.42 |
EPS (Unit Curr.) | 7.07 | 30.57 | 30.37 | 33.27 | 19.25 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 80 | 80.03 | 80.03 | 77.59 | 74.49 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 27.34 | 26.31 | 29.38 | 32.55 | 28.41 |
PBDTM(%) | 24.51 | 24.66 | 27.83 | 31.6 | 25.82 |
PATM(%) | 13.77 | 14.18 | 16.47 | 20.37 | 15.11 |
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.